Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$11.52
$11.50
$5.57
$11.98
$397.94M1.11106,940 shs9,831 shs
DaVita Inc. stock logo
DVA
DaVita
$144.26
+1.0%
$140.10
$131.76
$179.60
$10.89B1.11807,105 shs385,062 shs
HemaCare Co. stock logo
HEMA
HemaCare
$25.31
+0.6%
$25.31
$8.62
$26.23
$346.52M1.4739,950 shs5,400 shs
Progyny, Inc. stock logo
PGNY
Progyny
$23.68
+10.4%
$21.75
$13.39
$30.42
$2.03B1.311.71 million shs1.90 million shs
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$32.50
$32.50
$21.25
$32.89
$1.62B2.14820,051 shs1,170 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00%0.00%0.00%0.00%0.00%
DaVita Inc. stock logo
DVA
DaVita
+0.11%+0.22%+3.45%-0.64%+4.59%
HemaCare Co. stock logo
HEMA
HemaCare
0.00%0.00%0.00%0.00%0.00%
Progyny, Inc. stock logo
PGNY
Progyny
0.00%-2.50%-1.06%-0.28%-24.58%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
4.2731 of 5 stars
2.01.00.04.52.41.73.8
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
1.0352 of 5 stars
1.22.00.00.01.72.51.3
Tivity Health, Inc. stock logo
TVTY
Tivity Health
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
0.00
N/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
2.00
Hold$164.5014.03% Upside
HemaCare Co. stock logo
HEMA
HemaCare
0.00
N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
2.50
Moderate Buy$24.091.74% Upside
Tivity Health, Inc. stock logo
TVTY
Tivity Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest DVA, PGNY, TVTY, HEMA, and ARA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/8/2025
Progyny, Inc. stock logo
PGNY
Progyny
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$28.00
5/19/2025
DaVita Inc. stock logo
DVA
DaVita
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$170.00 ➝ $164.00
5/12/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $21.00
(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
$822.52M0.48$1.69 per share6.80$2.59 per share4.45
DaVita Inc. stock logo
DVA
DaVita
$12.82B0.85$19.36 per share7.45$4.83 per share29.87
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
$1.17B1.74$0.38 per share62.19$4.96 per share4.77
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$481.25M3.37$1.95 per share16.70$2.39 per share13.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/A
DaVita Inc. stock logo
DVA
DaVita
$936.34M$10.0914.3011.350.986.63%176.11%4.66%8/5/2025 (Estimated)
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/A0.00N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
$54.34M$0.5741.5436.432.264.33%10.90%7.20%8/5/2025 (Estimated)
Tivity Health, Inc. stock logo
TVTY
Tivity Health
$104.91M$1.7119.0116.411.8217.25%75.94%13.65%N/A

Latest DVA, PGNY, TVTY, HEMA, and ARA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
DaVita Inc. stock logo
DVA
DaVita
$2.70N/AN/AN/A$3.36 billionN/A
8/5/2025Q2 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.42N/AN/AN/A$315.70 millionN/A
5/12/2025Q1 2025
DaVita Inc. stock logo
DVA
DaVita
$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion
5/8/2025Q1 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.45$0.17-$0.28$0.17$307.86 million$324.04 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
N/AN/AN/AN/AN/A
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
Tivity Health, Inc. stock logo
TVTY
Tivity Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
7.54
1.05
1.02
DaVita Inc. stock logo
DVA
DaVita
23.18
1.25
1.20
HemaCare Co. stock logo
HEMA
HemaCare
N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.39
2.39
Tivity Health, Inc. stock logo
TVTY
Tivity Health
2.97
2.47
2.47

Institutional Ownership

CompanyInstitutional Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
78.42%
DaVita Inc. stock logo
DVA
DaVita
90.12%
HemaCare Co. stock logo
HEMA
HemaCare
N/A
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
91.54%

Insider Ownership

CompanyInsider Ownership
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
9.50%
DaVita Inc. stock logo
DVA
DaVita
2.00%
HemaCare Co. stock logo
HEMA
HemaCare
26.20%
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
Tivity Health, Inc. stock logo
TVTY
Tivity Health
2.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Renal Associates Holdings, Inc. stock logo
ARA
American Renal Associates
4,97734.54 millionN/AOptionable
DaVita Inc. stock logo
DVA
DaVita
76,00075.50 million73.99 millionOptionable
HemaCare Co. stock logo
HEMA
HemaCare
N/A13.69 millionN/ANot Optionable
Progyny, Inc. stock logo
PGNY
Progyny
31085.72 million77.66 millionOptionable
Tivity Health, Inc. stock logo
TVTY
Tivity Health
38049.93 million48.92 millionOptionable

Recent News About These Companies

Tivity Must Face Investor Claims Over Nutrisystem Acquisition
Tivity Health Denied Immediate Appeal Over Investor Class Status
10 Foods for Thyroid Health—And 3 To Avoid
Franklin-based health care company names new CEO
Tivity CEO moves to Amedisys top spot
TVTY.O
TVTY.OQ
SilverSneakers Announces 2022 Member of the Year

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
American Renal Associates stock logo

American Renal Associates NYSE:ARA

American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.

DaVita stock logo

DaVita NYSE:DVA

$144.26 +1.45 (+1.02%)
As of 01:39 PM Eastern

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

HemaCare stock logo

HemaCare OTCMKTS:HEMA

$25.31 +0.15 (+0.60%)
As of 01/3/2020

HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy. It offers human blood cellular components derived from peripheral blood, bone marrow, and cord blood; and a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company's network of FDA-registered, GMP/GTP-compliant collection centers ensures donor materials available to customers, as well as for use within its isolation laboratory. The company has strategic partnership with Charles River Laboratories International Inc. for human immune system research. HemaCare Corporation was founded in 1978 and is headquartered in Northridge, California.

Progyny stock logo

Progyny NASDAQ:PGNY

$23.68 +2.23 (+10.40%)
As of 01:40 PM Eastern

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Tivity Health stock logo

Tivity Health NASDAQ:TVTY

Tivity Health, Inc. provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine. It also provides Wisely Well brand meals designed to support individuals and caregivers who are seeking meal convenience, as well as those recovering after a hospitalization or living with chronic conditions. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was incorporated in 1981 and is headquartered in Franklin, Tennessee.